Incyte is headquartered in Wilmington, Delaware.
Incyte disclosed revenue of 4,241M USD for 2024 and 3,696M USD for 2023.
Incyte has 2,617 employees.
Incyte is a life science company.
Incyte was founded in 1991.
1801 Augustine Cut-Off,
Wilmington, Delaware
19803
United States,
(302) 498-6700
www.incyte.com
Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. Incyte was founded in 1991 and is based in Wilmington, Delaware.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.4/yr) | # | 3 | - | 1 | - | 1 | - | 5 |
| vol | $182M | $1.4B | $1.5B | |||||
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 5 | ||||||||
| Legal | Deals |
|---|---|
|
Covington & Burling |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
